Iteos Therapeutics Inc
NASDAQ:ITOS

Watchlist Manager
Iteos Therapeutics Inc Logo
Iteos Therapeutics Inc
NASDAQ:ITOS
Watchlist
Price: 8.34 USD -5.55% Market Closed
Market Cap: 304.6m USD
Have any thoughts about
Iteos Therapeutics Inc?
Write Note

Iteos Therapeutics Inc
Pre-Tax Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Iteos Therapeutics Inc
Pre-Tax Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors

Company Pre-Tax Income CAGR 3Y CAGR 5Y CAGR 10Y
Iteos Therapeutics Inc
NASDAQ:ITOS
Pre-Tax Income
-$109m
CAGR 3-Years
-42%
CAGR 5-Years
-43%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Pre-Tax Income
$7.2B
CAGR 3-Years
0%
CAGR 5-Years
19%
CAGR 10-Years
4%
Gilead Sciences Inc
NASDAQ:GILD
Pre-Tax Income
$176m
CAGR 3-Years
-73%
CAGR 5-Years
-47%
CAGR 10-Years
-34%
Amgen Inc
NASDAQ:AMGN
Pre-Tax Income
$4.7B
CAGR 3-Years
-10%
CAGR 5-Years
-13%
CAGR 10-Years
-1%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Pre-Tax Income
$259.6m
CAGR 3-Years
-54%
CAGR 5-Years
-19%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Pre-Tax Income
$5B
CAGR 3-Years
-15%
CAGR 5-Years
18%
CAGR 10-Years
21%

See Also

What is Iteos Therapeutics Inc's Pre-Tax Income?
Pre-Tax Income
-109m USD

Based on the financial report for Dec 31, 2023, Iteos Therapeutics Inc's Pre-Tax Income amounts to -109m USD.

What is Iteos Therapeutics Inc's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 5Y
-43%

The average annual Pre-Tax Income growth rates for Iteos Therapeutics Inc have been -42% over the past three years , -43% over the past five years .

Back to Top